Insights into the activity control of the kallikrein-related peptidase 6: small-molecule modulators and allosterism
Résumé
The activity of kallikrein-related peptidase 6 (KLK6) is deregulated in various diseases such as cancer and neurodegenerative diseases. KLK6 is thus considered as an attractive therapeutical target. In this short report, we depict some novel findings on the regulation of the KLK6 activity. Namely, we identified mechanismbased inhibitors (suicide substrates) from an in-house library of 6-substituted coumarin-3-carboxylate derivatives. In addition, a molecular dynamics study evidenced the allosteric behavior of KLK6 similar to that previously observed for some trypsin-like serine proteases. This allosteric behavior together with the coumarinic scaffold bring new opportunities for the design of KLK6 potent activity modulators, useful as therapeutics or activitybased probes.
Fichier principal
KLK_BC 2018.pdf (468.15 Ko)
Télécharger le fichier
KLK7_Mol Onc 2017.pdf (2.5 Mo)
Télécharger le fichier
KLK7_eur jmedchem 2015.pdf (1 Mo)
Télécharger le fichier
KLK_JMedChem 2021.pdf (6.97 Mo)
Télécharger le fichier
KLKs_JMedChem 2015.pdf (5.24 Mo)
Télécharger le fichier
Org letters 2020.pdf (1.59 Mo)
Télécharger le fichier
SERS adenine_ejoc 2018.pdf (1.45 Mo)
Télécharger le fichier
SERS_JRS 2016.pdf (649.96 Ko)
Télécharger le fichier
Ser proteases_ExOpTherPat 2017.pdf (1.88 Mo)
Télécharger le fichier
Origine | Fichiers éditeurs autorisés sur une archive ouverte |
---|